Brief: Biosenic On Its Way To Find Funds For Clinical Trial On Chronic Graft-Versus-Host Disease

Biosenic SA

06/12/2023 06:03

Dec 6 (Reuters) - Biosenic SA  BIOS.BR :
    * BIOSENIC ON ITS WAY TO FIND THE NECESSARY FUNDS TO PERFORM
ITS
KEY CLINICAL TRIAL ON CHRONIC GRAFT-VERSUS-HOST DISEASE
    * SIGNS TERM SHEET WITH SPRIM GLOBAL INVESTMENTS (TRIALCAP
FUND)
FOR UP TO USD 8 MILLION DEBT FINANCING
    * IN ACCORDANCE WITH TERM SHEET, LENDER WILL PROVIDE TWO
TERM LOAN
FACILITIES OF EACH UP TO USD 4,000,000
    * IN ADDITION, UNDER TERM SHEET, LENDER INTENDS TO MAKE AN
EQUITY
INVESTMENT OF USD 800,000 IN NEW SHARES OF BIOSENIC
    * WILL ALSO ISSUE WARRANTS EQUAL TO 20% OF TOTAL AMOUNTS
DRAWN
UNDER LOAN FACILITIES

Source text for Eikon:  ID:nGNE8CNNnl 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))